BioCentury | Jan 18, 2018
Emerging Company Profile

Computing brain entry

...as possible.” Behind 1ST-102, 1st Biotherapeutics has four discovery programs against undisclosed targets. 1ST-101 and 1ST-103...
...say whether they are specifically meant to treat CNS cancers. The company hopes to bring 1ST-103...
Items per page:
1 - 1 of 1